sever
patient
account
mortal
diseas
earli
detect
effect
treatment
sever
patient
remain
major
challeng
perform
proteom
metabolom
profil
sera
control
individu
train
machin
learn
model
use
proteom
metabolom
measur
train
cohort
nonsever
sever
patient
model
correctli
classifi
sever
patient
accuraci
valid
use
ten
independ
patient
seven
correctli
classifi
identifi
molecular
chang
sera
patient
implic
dysregul
macrophag
platelet
degranul
complement
system
pathway
massiv
metabol
suppress
studi
show
possibl
predict
progress
sever
diseas
use
serum
protein
metabolit
biomark
data
also
uncov
molecular
pathophysiolog
potenti
develop
antivir
therapi
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
perform
later
diseas
stage
use
stabl
isotop
label
proteom
strategi
tmtpro
li
identif
sever
patient
use
machin
learn
next
investig
possibl
classifi
sever
patient
base
molecular
signatur
protein
metabolit
tabl
built
random
forest
machin
learn
model
base
proteom
reason
incorrectli
classifi
unclear
test
model
independ
cohort
ten
patient
figur
tabl
sever
patient
correctli
identifi
except
one
previous
report
liang
et
al
report
elev
sever
sar
patient
specif
sarccov
pang
et
al
major
contributor
acut
phase
respons
complement
system
play
crucial
role
elimin
invad
pathogen
earli
stage
infect
among
app
two
protein
belong
complement
membran
attack
complex
includ
complement
also
observ
accumul
mannos
deriv
sever
patient
complement
system
bind
mannos
lectin
lead
cleaveag
form
convertas
promot
complement
activ
ricklin
et
al
suppress
platelet
degranul
sever
sera
fifteen
protein
involv
platelet
degranul
regul
infect
patient
may
associ
observ
thrombocytopenia
patient
cohort
zheng
et
al
low
platelet
count
also
report
associ
sever
p
p
respect
also
detect
low
level
fatti
acid
arachidon
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
seven
patient
correctli
classifi
independ
valid
cohort
contain
ten
patient
two
could
explain
patient
complex
comorbid
medic
histori
rel
small
sampl
size
necessit
futur
valid
studi
independ
cohort
data
shed
light
molecular
chang
reflect
sera
could
potenti
yield
critic
diagnost
marker
therapeut
target
manag
sever
patient
figur
molecular
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
proteom
data
show
protein
relat
platelet
degranul
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
jiang
zhao
g
song
n
li
p
chen
guo
li
j
du
l
jiang
guo
r
et
al
blockad
axi
allevi
lung
damag
mice
infect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
lung
injuri
influenza
pneumon
j
pathol
nie
zhao
x
zhao
k
zhang
z
zhang
z
zhang
z
metabol
disturb
inflammatori
dysfunct
predict
sever
coronaviru
diseas
retrospect
studi
medrxiv
medrxiv
medrxiv
zou
z
yang
chen
j
xin
zhang
w
zhou
x
mao
hu
l
liu
chang
b
et
al
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
tabl
patient
label
red
yaxi
indic
chronic
infect
virus
includ
hbv
b
studi
design
machin
learningbas
classifi
develop
sever
patient
first
procur
sampl
train
cohort
proteom
metabolom
analysi
classifi
valid
independ
cohort
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
public
health
medic
center
januari
februari
peptid
ntermini
precursor
ion
mass
toler
set
ppm
product
ion
mass
toler
set
da
peptidespectrummatch
allow
target
fals
discoveri
rate
fdr
strict
target
fdr
relax
normal
perform
total
peptid
amount
paramet
follow
default
setup
qualiti
control
proteom
data
qualiti
proteom
data
ensur
multipl
level
first
mous
liver
digest
use
instrument
perform
evalu
also
run
water
sampl
buffer
blank
everi
inject
avoid
carryov
mobil
solut
use
gradient
elut
water
methanol
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
raw
data
preprocess
peak
findingalign
peak
annot
use
inhous
softwar
metabolit
identifi
search
inhous
librari
contain
standard
librari
data
entri
gener
run
purifi
compound
standard
metabolit
therapeut
compound
miss
ratio
particular
patient
group
remov
metabolom
dataset
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
hochberg
correct
statist
significantli
chang
protein
metabolit
select
use
criteria
adjust
p
valu
less
indic
absolut
fc
larger
train
cohort
import
featur
select
mean
decreas
accuraci
larger
use
random
forest
contain
thousand
tree
use
r
packag
randomforest
version
random
forest
analysi
cross
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
figur
